Amino Acid Polymorphisms on the Brazilian Strain of Yellow Fever Virus Methyltransferase Are Related to the Host's Immune Evasion Mediated by Type I Interferon

Viruses. 2023 Jan 10;15(1):191. doi: 10.3390/v15010191.

Abstract

Since late 2016, a yellow fever virus (YFV) variant carrying a set of nine amino acid variations has circulated in South America. Three of them were mapped on the methyltransferase (MTase) domain of viral NS5 protein. To assess whether these changes affected viral infectivity, we synthesized YFV carrying the MTase of circulating lineage as well as its isoform with the residues of the previous strains (NS5 K101R, NS5 V138I, and NS5 G173S). We observed a slight difference in viral growth properties and plaque phenotype between the two synthetic YFVs. However, the MTase polymorphisms associated with the Brazilian strain of YFV (2016-2019) confer more susceptibility to the IFN-I. In addition, in vitro MTase assay revealed that the interaction between the YFV MTase and the methyl donor molecule (SAM) is altered in the Brazilian MTase variant. Altogether, the results reported here describe that the MTase carrying the molecular signature of the Brazilian YFV circulating since 2016 might display a slight decrease in its catalytic activity but virtually no effect on viral fitness in the parameters comprised in this study. The most marked influence of these residues stands in the immune escape against the antiviral response mediated by IFN-I.

Keywords: methyltransferase; type I interferon; virulence; yellow fever virus outbreak.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids
  • Brazil
  • Immune Evasion
  • Interferon Type I* / genetics
  • Methyltransferases / metabolism
  • Viral Nonstructural Proteins / genetics
  • Yellow fever virus* / physiology

Substances

  • Interferon Type I
  • Amino Acids
  • Methyltransferases
  • Viral Nonstructural Proteins

Grants and funding

This work was supported by MCTI/FINEP/FNDCT 01/2016 (Grant n° 04.16.0058.04); Preventing and Combating the Zika Virus, MCTIC/FNDCT-CNPq/MEC524 CAPES/MS-Decit. (Grant n°. 440865/2016–6), Preventing and Combating the Zika Virus MCTIC/FNDCT CNPq/MEC-CAPES/MS-Decit. (Grant n°. 88881130684/2016–00). MCB is a recipient of the fellowships for Productivity in Technological Development and Innovative Extension (308164/2020–2; CNPq) and Cientistas do Nosso Estado (E-26/201.207/2021; FAPERJ). GO acknowledges Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP Project 2013/07600-3). ED and BC were supported by the European project Zikalliance (n° 734548 H2020).